Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Judge dismisses Seroquel product liability suits

Executive Summary

A judge threw out two lawsuits claiming AstraZeneca failed to provide adequate warning that its atypical antipsychotic Seroquel (quetiapine) increased the risk of diabetes. The suits, brought by Anne Guinn and David Haller, are among more than 7,000 pending in multidistrict litigation in the U.S. District Court of the Middle District of Florida. They were selected as test cases for trial and, on Jan. 30, U.S. District Judge Anne Conway granted AstraZeneca's motion for summary judgment in both. In the Guinn case she ruled that there is "no evidence in the record from which a reasonable juror could conclude that Seroquel contributed substantially to producing Guinn's injury.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS050658

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel